Product Information

PITAVASTATIN 2 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.9865 per EA under NDC 72603047901. Its NADAC has been published 69 times since Apr 30, 2025.

FDA first approved this application on Apr 30, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the pitavastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PITAVASTATIN 2 MG TABLET

pitavastatin calcium
$0.9865per EA
High Outlier

Strength

2.09 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603047901

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA205977

FDA Approved

4/30/2024

TE Code

AB

On Market Since

12/1/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 2 MG TABLET has been published 69 times since Apr 30, 2025, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9865 per EA
All-time high$1.5515 (Jul 16, 2025)
All-time low$0.9865 (Aug 19, 2026)
52-week high$1.4992
52-week low$0.9865
Median price$1.3312
Average price$1.3460
Largest weekly change-10.2% (Jul 22, 2026)
Weeks tracked69
Tracking sinceApr 30, 2025

Price History

1W

-4.7%

1M

-4.7%

3M

-18.9%

6M

-23.5%

1Y

-34.2%

3Y

N/A

5Y

N/A

All

-35.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by NorthStar Rx LLC, is $0.9865 per EA (NDC 72603047901), effective Aug 19, 2026.

How has the price of PITAVASTATIN 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 35.5%. It has been tracked across 69 weekly CMS publications since Apr 30, 2025.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?

Since Apr 30, 2025, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9865 (Aug 19, 2026) to a high of $1.5515 (Jul 16, 2025), with a median of $1.3312 per EA.

Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PITAVASTATIN 2 MG TABLET?

PITAVASTATIN 2 MG TABLET (NDC 72603047901) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.